Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial
Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.

Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record's revision history now includes a new entry for version v3.6.3 and removes the previous v3.6.2 entry, updating the list of recorded revisions to reflect the latest posting.SummaryDifference0.1%

- Check19 days agoChange DetectedA newer revision entry v3.6.2 was added to the record history, and the earlier v3.6.0 entry was removed. This updates the visible version history of the study record.SummaryDifference0.1%

- Check34 days agoChange DetectedA new revision entry v3.6.0 was added to the study record history, replacing the previous v3.5.5. This indicates an update to the record's documentation.SummaryDifference0.5%

- Check41 days agoChange DetectedA new revision entry, v3.5.5, was added to the study history, and the previous revision, v3.5.4, was removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe record history now displays Revision: v3.5.4, replacing the previous v3.5.3. This reflects a minor metadata update to the page's revision history rather than a change to study content.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision, v3.5.3, was added to the record history, replacing the previous revision, v3.5.2. This indicates an update to the page's version metadata.SummaryDifference0.1%

Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.